Treatment trial methodology in internal medicine

被引:1
作者
Mahe, Isabelle
Bosquet, Antoine
Bartolucci, Pablo
Rist, Stephanie
Bergmann, Jean-Francois
机构
[1] Hop Louis Mourier, Serv Med Interne 5, F-92700 Colombes, France
[2] Hop Lariboisiere, APHP, Serv Med A, F-75475 Paris, France
来源
PRESSE MEDICALE | 2007年 / 36卷 / 03期
关键词
D O I
10.1016/j.lpm.2007.01.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical trials are the foundation of therapeutic evaluation. Their interpretation and usefulness depend on their compliance with strict methodological rules. Departments of internal medicine admit patients with many different diseases, G variety that makes it difficult to organize and conduct clinical trials in their standard form. This article reviews the rules of clinical trials that are essential to their validity and reliability The prospective randomized double-blinded clinical trial is the most scientifically rigorous method for assessing treatment. Rare diseases and those involving several specialties can and should be performed in accordance with the standard methodological rules, despite their particular aspects. This article considers ways to improve the participation of departments of internal medicine to future clinical trials.
引用
收藏
页码:512 / 518
页数:7
相关论文
共 50 条